
    
      This study is meant to determine specific pneumococcal antibodies stratified for age. The
      investigators also correlate our assay with the results from a commercially available
      pneumococcal screening ELISA (iGG1 and IgG2) in order to facilitate a screening for
      immunodeficiency, and to monitor the success of a performed immunization
    
  